Karasakal A, Ulu S T
Department of Chemistry, Faculty of Science and Letters, Namik Kemal University, Tekirdag, Turkey.
Luminescence. 2014 May;29(3):239-42. doi: 10.1002/bio.2534. Epub 2013 Jul 12.
A novel, sensitive and selective spectrofluorimetric method was developed for the determination of tamsulosin in spiked human urine and pharmaceutical preparations. The proposed method is based on the reaction of tamsulosin with 1-dimethylaminonaphthalene-5-sulfonyl chloride in carbonate buffer pH 10.5 to yield a highly fluorescent derivative. The described method was validated and the analytical parameters of linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy, precision, recovery and robustness were evaluated. The proposed method showed a linear dependence of the fluorescence intensity on drug concentration over the range 1.22 × 10(-7) to 7.35 × 10(-6) M. LOD and LOQ were calculated as 1.07 × 10(-7) and 3.23 × 10(-7) M, respectively. The proposed method was successfully applied for the determination of tamsulosin in pharmaceutical preparations and the obtained results were in good agreement with those obtained using the reference method.
建立了一种新颖、灵敏且具选择性的荧光分光光度法,用于测定加标人尿和药物制剂中的坦索罗辛。该方法基于坦索罗辛与1-二甲基氨基萘-5-磺酰氯在pH值为10.5的碳酸盐缓冲液中反应,生成一种高荧光衍生物。对所描述的方法进行了验证,并评估了线性、检测限(LOD)、定量限(LOQ)、准确度、精密度、回收率和稳健性等分析参数。该方法显示荧光强度与药物浓度在1.22×10⁻⁷至7.35×10⁻⁶ M范围内呈线性关系。检测限和定量限分别计算为1.07×10⁻⁷和3.23×10⁻⁷ M。该方法成功应用于药物制剂中坦索罗辛的测定,所得结果与参考方法获得的结果高度一致。